Investment
Features
FeesSafety
Academy
More
Pluang+

New US ETF offers Tron TRX exposure with staking rewards starting September 9 on Cboe.

Market News
08 Sep 2026
Crypto Briefing
View Source
Bullish
New US ETF offers Tron TRX exposure with staking rewards starting September 9 on Cboe.

Canary Capital will launch the first US ETF that provides direct exposure to Tron’s TRX token while staking the assets to generate yield. Trading under the ticker TRXS, the fund will begin on September 9 on the Cboe BZX Exchange. Investors can earn staking rewards automatically as the fund stakes at least 90% of its TRX holdings, with rewards boosting the ETF’s share price rather than being paid out separately. This product could set a precedent for staking-enabled crypto ETFs in the US market, which have faced regulatory hurdles until now.

More News

Lakeland Industries wins new contracts despite ongoing losses and negative EPS forecast.

Lakeland Industries wins new contracts despite ongoing losses and negative EPS forecast.

Lakeland Industries continues to face profitability challenges with a projected negative EPS of -$0.06 and recent unprofitability. However, the company secured important contracts with the Hong Kong Government Flying Service and Airports of Thailand,...

Company Fundamentals
Neutral
55 minutes ago
Intel shares jump on High-NA EUV tech progress and $120 price target upgrade

Intel shares jump on High-NA EUV tech progress and $120 price target upgrade

Intel's stock surged after Northland Securities upgraded it from "Market Perform" to "Outperform" with a $120 price target, following Intel Foundry's progress in High Numerical Aperture Extreme Ultraviolet (High-NA EUV) lithography. Intel has process...

Market News
Bullish
2 hours ago
ABM Industries beats Q3 EPS estimates with $1.04, posts record $2.3B revenue and strong cash flow.

ABM Industries beats Q3 EPS estimates with $1.04, posts record $2.3B revenue and strong cash flow.

ABM Industries reported strong Q3 2026 results, surpassing analyst EPS estimates with $1.04 per share versus the expected $1.01. The company achieved record revenue of $2.3 billion, a 4.2% increase driven by organic and acquisition growth. Adjusted n...

Company Fundamentals
Bullish
2 hours ago
GameStop Q2 earnings show revenue drop but focus on strategic fund use and financial health.

GameStop Q2 earnings show revenue drop but focus on strategic fund use and financial health.

GameStop is set to report its Q2 2026 earnings with analysts expecting an EPS of $0.27 and revenues around $756.85 million, down from $972.20 million the previous year. The company’s own sales forecast of $780-$800 million confirms a significant reve...

Company Fundamentals
Neutral
2 hours ago
Opus Genetics gets Buy rating ahead of key gene therapy data release on Sept 9, 2026.

Opus Genetics gets Buy rating ahead of key gene therapy data release on Sept 9, 2026.

Opus Genetics, a clinical-stage biotech focused on inherited retinal diseases, received a Buy rating and $8 price target from analyst Matthew Caufield in August 2026. The company plans to release topline Phase 1/2 data for its gene therapy OPGx-BEST1...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App